In vitro Neutralization Effect of SARS-CoV-2 Specific IgG Against Delta and Omicron Variants of COVID-19 Virus Using Vero E6 Cells

Author:

Purwati Purwati1,Ertanti Nora1,Karsari Deya1,Dinaryanti Aristika1,Hendrianto Eryk1,Ihsan Igo Syaiful1,Ardiana Asa1,Nurdiyati Nanis1,Wahyuni Afrinda Dwi1,Permanasari Adita Ayu1,Nurwito Bagus Satrio1,Shimizu Kazufumi,Nastri Aldise Mareta1,Lusida Maria Inge1,Miatmoko Andang1

Affiliation:

1. Airlangga University

Abstract

Abstract

Purpose This study aims to evaluate SARS-CoV-2 specific IgG (Immunoglobulin G) isolated from post inactive patients as passive immunization candidates. Patients and methods: Toxicity testing and virus neutralization parameters. IgG doses of 20, 40, and 60 µg/mL were tested for 3 and 6 days using CPE analysis, viral load, and immunocytochemistry. Results Following a 3-days incubation period, the Delta and Omicron variants caused similar levels of damage at 10–20%. However, after 6 days, the CPE (Cytopathic Effect) scoring of the Delta and Omicron variants increased by 70–80% and 50–60%, respectively. The optimal dose for viral neutralization was found to be 40 µg/mL, as it could spread evenly on the actin filament cells, envelop the cells appropriately, and inhibit the virus binding process. The dose was able to reduce virus copy load by up to 26% and 9.63% in the Delta and Omicron variants. Conclusion Based on the viral neutralization parameters (Cytopathic Effect, SARS-CoV-2 viral copy load, and immunocytochemistry) showing that the replication process and virulence of the Delta variant were more severe in comparison to the Omicron variant.

Publisher

Research Square Platform LLC

Reference8 articles.

1. World Health Organization: Tracking SARS-CoV-2 variants; (2022)

2. Development of SARS-CoV-2 specific IgG and virus-neutralizing antibodies after infection with variants of concern or vaccination;Neumann F;Vaccines,2021

3. Determination of the concentration of IgG against the spike receptor-binding domain that predicts the viral neutralizing activity of convalescent plasma and serum against SARS-CoV-2;Santiago L;Biology,2021

4. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application;Lauer SA;Ann. Intern. Med.,2020

5. Inayat-Hussain, S., Rajab, N.F., Siew, E.L.: In vitro testing of biomaterials toxicity and biocompatibility. In Cellular Response to Biomaterials. :508–537. (2009)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3